Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2008 1
2011 1
2013 2
2014 3
2015 1
2016 2
2018 1
2019 4
2020 11
2021 7
2022 11
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis.
Jou E, Rodriguez-Rodriguez N, Ferreira AF, Jolin HE, Clark PA, Sawmynaden K, Ko M, Murphy JE, Mannion J, Ward C, Matthews DJ, Buczacki SJA, McKenzie ANJ. Jou E, et al. Among authors: rodriguez rodriguez n. Sci Immunol. 2022 Jun 3;7(72):eabn0175. doi: 10.1126/sciimmunol.abn0175. Epub 2022 Jun 3. Sci Immunol. 2022. PMID: 35658010 Free PMC article.
Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
Rodriguez-Rodriguez N, Clark PA, Gogoi M, Ferreira ACF, Kerscher B, Crisp A, Jolin HE, Murphy JE, Sivasubramaniam M, Pedro L, Walker JA, Heycock MWD, Shields JD, Barlow JL, McKenzie ANJ. Rodriguez-Rodriguez N, et al. Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2203454119. doi: 10.1073/pnas.2203454119. Epub 2022 Nov 29. Proc Natl Acad Sci U S A. 2022. PMID: 36442116 Free PMC article.
Regulation of activated T cell survival in rheumatic autoimmune diseases.
Rosetti F, Madera-Salcedo IK, Rodríguez-Rodríguez N, Crispín JC. Rosetti F, et al. Among authors: rodriguez rodriguez n. Nat Rev Rheumatol. 2022 Apr;18(4):232-244. doi: 10.1038/s41584-021-00741-9. Epub 2022 Jan 24. Nat Rev Rheumatol. 2022. PMID: 35075294 Review.
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients.
Rodríguez-Rodríguez N, Martínez-Jiménez I, García-Ojalvo A, Mendoza-Mari Y, Guillén-Nieto G, Armstrong DG, Berlanga-Acosta J. Rodríguez-Rodríguez N, et al. MEDICC Rev. 2021 Sep 17;24(1):44-58. doi: 10.37757/MR2021.V23.N3.8. eCollection 2022 Jan 31. MEDICC Rev. 2021. PMID: 34653116 Free article. Review.
Down-Regulation-Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon-γ Production.
Madera-Salcedo IK, Ramírez-Sánchez AL, Rodríguez-Rodríguez N, García-Quintero R, Rubio RM, Morales-Montes de Oca G, Dávalos E, Cuervo R, Furuzawa-Carballeda J, Alcocer-Varela J, Gómez-Martín D, González-Yáñez M, de la Cruz A, Albarrán-Godínez A, Suárez-Rojas G, Romero-Díaz J, Uribe-Uribe NO, Alarcón-Riquelme M, Furlan-Magaril M, Mejía-Vilet JM, Crispín JC, Rosetti F. Madera-Salcedo IK, et al. Among authors: rodriguez rodriguez n. Arthritis Rheumatol. 2023 Jun;75(6):961-972. doi: 10.1002/art.42435. Epub 2023 Mar 22. Arthritis Rheumatol. 2023. PMID: 36575804
Review: Insulin resistance and mitochondrial dysfunction following severe burn injury.
Berlanga-Acosta J, Iglesias-Marichal I, Rodríguez-Rodríguez N, Mendoza-Marí Y, García-Ojalvo A, Fernández-Mayola M, Playford RJ. Berlanga-Acosta J, et al. Among authors: rodriguez rodriguez n. Peptides. 2020 Apr;126:170269. doi: 10.1016/j.peptides.2020.170269. Epub 2020 Feb 8. Peptides. 2020. PMID: 32045621 Review.
Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity.
Berlanga-Acosta JA, Guillén-Nieto GE, Rodríguez-Rodríguez N, Mendoza-Mari Y, Bringas-Vega ML, Berlanga-Saez JO, García Del Barco Herrera D, Martinez-Jimenez I, Hernandez-Gutierrez S, Valdés-Sosa PA. Berlanga-Acosta JA, et al. Among authors: rodriguez rodriguez n. Front Endocrinol (Lausanne). 2020 Sep 16;11:573032. doi: 10.3389/fendo.2020.573032. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33042026 Free PMC article. Review.
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
Montgomery H, Hobbs FDR, Padilla F, Arbetter D, Templeton A, Seegobin S, Kim K, Campos JAS, Arends RH, Brodek BH, Brooks D, Garbes P, Jimenez J, Koh GCKW, Padilla KW, Streicher K, Viani RM, Alagappan V, Pangalos MN, Esser MT; TACKLE study group. Montgomery H, et al. Lancet Respir Med. 2022 Oct;10(10):985-996. doi: 10.1016/S2213-2600(22)00180-1. Epub 2022 Jun 7. Lancet Respir Med. 2022. PMID: 35688164 Free PMC article. Clinical Trial.
41 results